Los puntos clave no están disponibles para este artículo en este momento.
TRE is implementable, acceptable, and safe in populations with overweight, obesity, prediabetes, or type 2 diabetes, but it should be accompanied by support and options for individual adjustments.
Termannsen et al. (Fri,) studied this question.